伴侣动物诊断市场规模、份额和成长分析（按技术、动物种类、应用、最终用户和地区划分）－2026-2033年产业预测

预计到 2024 年，伴侣动物诊断市场规模将达到 26.5 亿美元，到 2025 年将达到 29 亿美元，到 2033 年将达到 59.4 亿美元，在预测期（2026-2033 年）内复合年增长率为 9.4%。

宠物慢性病发病率的上升趋势正在推动伴侣动物诊断技术的进步，尤其是在越来越多的宠物饲主认识到兽医护理的重要性之后。犬猫糖尿病等疾病的显着增加便是这一趋势的例证。犬猫主人数量的增长表明社会对伴侣动物的接受度不断提高，从而推动了该行业的收入成长。市场对能够有效处理检体和进行全面疾病筛检的自动化和半自动化诊断测试有着巨大的需求。此外，用于早期发现糖尿病的血糖监测技术的普及也推动了市场潜力。对照护现场诊断（POCD）快速检测的日益重视也在塑造着市场动态，各公司正投资研发创新诊断解决方案以满足这一不断增长的需求。

伴侣动物诊断市场驱动因素

由于携带式诊断工具的兴起，伴侣动物诊断市场蓬勃发展，这些工具能够实现动物疾病的照护现场检测。领先的製造商正致力于开发这些移动工具，特别是针对第一线兽医的工具，使他们能够在家庭、收容所等偏远地区以及紧急情况下进行诊断。兽医对即时诊断解决方案日益增长的需求推动了这些可携式系统的应用。这些系统不仅简化了资料收集流程，也加强了大规模兽医诊所和研究机构内部各部门之间的沟通。

伴侣动物诊断市场限制因素

伴侣动物诊断市场面临许多可能阻碍其成长的重大挑战。宠物照护成本的不断上涨抑制了饲主寻求必要诊断服务的意愿，从而影响了整体需求。此外，发展中地区兽医短缺加剧了这个问题，限制了动物获得基本医疗服务的机会。同时，宠物饲主普遍缺乏兽医知识也阻碍了市场扩张，因为这种知识不足会导致诊断服务的使用率不足。这些因素共同构成了伴侣动物诊断市场成长的重大障碍，需要采取策略性措施来克服这些障碍。

伴侣动物诊断市场趋势

伴侣动物诊断市场的一个显着趋势是，旨在改善宠物诊断设备的研发活性化不断增加。这主要源自于人们认识到SARS-CoV-2等感染疾病与伴侣动物健康状况之间存在流行病学联繫，凸显了伴侣动物对公共卫生和生物多样性的重要性。卫生部门之间的合作正在促进对通用的感染疾病传播进行积极监测，尤其是在与COVID-19阳性患者接触过的犬猫中。这些努力不仅旨在保护动物健康，也标誌着兽医诊断正被纳入更广泛的健康监测框架。

目录

介绍

• 调查目标
• 调查范围
• 定义

调查方法

• 资讯收集
• 二手资料和一手资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态与展望

• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特分析及其影响

关键市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 市场吸引力指数（2025）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 技术进步
• 监管环境
• 案例研究

全球伴侣动物诊断市场规模（按类型和复合年增长率划分）（2026-2033 年）

• 临床生物化学
  • 临床化学分析
  • 试剂、夹子、墨盒
  • 分析器
  • 血糖监测
  • 血糖试纸
  • 血糖值监测仪
  • 尿糖试纸
  • 血气和电解质分析
  • 试剂、夹子、墨盒
  • 血液气体和电解质分析仪
• 免疫诊断
  • 横向流动化验
  • 快速检测
  • 试纸条阅读器（侧向流读取仪）
  • ELISA检测
  • 过敏原特异性免疫诊断试验
  • 免疫检测分析仪
  • 用于免疫诊断的其他动物物种
• 血液学
  • 墨水匣
  • 分析器
• 尿液检查
  • 卡扣式墨盒/面板
  • 尿液分析仪
  • 尿液检查检测试纸
• 分子诊断
  • 聚合酵素链锁反应检测
  • 微阵列
  • 其他用于分子诊断的动物物种
• 其他伴侣动物诊断技术

全球伴侣动物诊断市场规模（以动物类型划分）及复合年增长率（2026-2033 年）

• 狗
• 猫
• 马
• 其他伴侣动物

全球伴侣动物诊断市场规模（按应用领域及复合年增长率划分）（2026-2033 年）

• 临床病理
• 细菌学
• 病毒学
• 寄生虫学
• 其他用途

全球伴侣动物诊断市场规模（按最终用户划分）及复合年增长率（2026-2033 年）

• 诊断检查室
• 兽医医院和诊所
• 研究机构和大学
• 居家照护环境

全球伴侣动物诊断市场规模及复合年增长率（2026-2033）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 英国
  • 德国
  • 西班牙
  • 法国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 依业务板块进行公司股票分析
  • 2021-2023年营收年比比较

主要企业简介

• Idexx Laboratories, Inc.
• Zoetis Inc.
• Thermo Fisher Scientific Inc.
• Biomerieux SA
• Virbac
• Neogen Corporation
• Fujifilm Holdings Corporation
• Indical Bioscience GmbH
• Idvet
• Randox Laboratories, Ltd.
• Bionote, Inc.
• Skyla Corporation
• Urit Medical Electronic Co., Ltd.
• Nova Biomedical
• Fassisi GmbH
• Swissavans AG
• Alvedia
• Megacor Veterinary Diagnostics
• Biopanda Reagents Ltd
• Anipoc Ltd
• Ring Biotechnology Co Ltd.

结论与建议

Companion Animal Diagnostics Market size was valued at USD 2.65 Billion in 2024 and is poised to grow from USD 2.9 Billion in 2025 to USD 5.94 Billion by 2033, growing at a CAGR of 9.4% during the forecast period (2026-2033).

The growing prevalence of chronic health issues in pets is driving advancements in companion animal diagnostics, particularly as more pet owners recognize the importance of veterinary care. Significant rises in conditions such as canine and feline diabetes are indicative of this trend. The increasing number of households with dogs and cats underlines a broader acceptance of companion animals, fostering revenue growth in the sector. There is a notable demand for automated and semi-automated diagnostic tests that facilitate efficient sample handling and comprehensive disorder screening. Additionally, the surge in glucose monitoring capabilities for early diabetes detection enhances market potential. The emphasis on Point of Care Diagnostics (POCD) for quick test results is further shaping market dynamics, as companies invest in innovative diagnostic solutions to meet this burgeoning demand.

Top-down and bottom-up approaches were used to estimate and validate the size of the Companion Animal Diagnostics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Companion Animal Diagnostics Market Segments Analysis

Global Companion Animal Diagnostics Market is segmented by Technology, Animal Type, Application, End User, and region. Based on Technology, the market is segmented into Clinical biochemistry, Immunodiagnostics, Hematology, Urinalysis, Molecularity Molecular diagnostics, and Other Companion Animal Diagnostic Technologies. Based on Animal Type, the market is segmented into Dogs, Cats, Horses, and Other companion animals. Based on Application, the market is segmented into Clinical Pathology, Bacteriology, Virology, Parasitology, and Other Applications. Based on End User, the market is segmented into Diagnostic Laboratories, Veterinary Hospitals & Clinics, Research Institutes & Universities, and Home-care Settings. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Companion Animal Diagnostics Market

The Companion Animal Diagnostics market is experiencing growth due to the rise of portable diagnostic tools that facilitate point-of-care services for detecting animal illnesses. Leading manufacturers are focusing on developing these mobile tools specifically for field veterinarians, enabling them to conduct diagnostics in remote locations such as homes or shelters, as well as during emergencies. The increasing demand among veterinarians for immediate diagnostic solutions is motivating the adoption of these portable systems, which not only streamline the process of gathering data but also enhance communication across various departments within larger veterinary hospitals and research institutions.

Restraints in the Companion Animal Diagnostics Market

The Companion Animal Diagnostics market faces several significant challenges that may hinder its growth. Rising costs associated with pet care can deter pet owners from seeking necessary diagnostic services, impacting overall demand. Furthermore, a shortage of veterinarians in developing regions compounds this issue, limiting access to essential healthcare for animals. Additionally, a general lack of awareness regarding animal healthcare among pet owners further obstructs market expansion, as insufficient knowledge can lead to underutilization of diagnostic services. These factors combined present formidable barriers to the growth of the Companion Animal Diagnostics market, necessitating strategic approaches to overcome them.

Market Trends of the Companion Animal Diagnostics Market

The Companion Animal Diagnostics market is experiencing a notable trend towards increased research and development aimed at enhancing diagnostic devices for pets. This surge is driven by the recognition of the epidemiological connections between infectious diseases, such as SARS-CoV-2, and the health of companion animals, underscoring their importance in public health and biodiversity. Collaborative efforts among health authorities are facilitating proactive monitoring of potential zoonotic transmissions, especially in cats and dogs in contact with COVID-19-positive individuals. Such initiatives not only aim to safeguard animal health but also highlight the integration of veterinary diagnostics into broader health surveillance frameworks.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Driver & Opportunities
  • Restraints & Challenges
• Porters Analysis & Impact
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technological Advancement
• Regulatory Landscape
• Case Studies

Global Companion Animal Diagnostics Market Size by Type & CAGR (2026-2033)

• Market Overview
• Clinical biochemistry
  • Clinical chemistry analysis
  • Reagents, clips, and cartridges
  • Analyzers
  • Glucose monitoring
  • Blood glucose strips
  • Glucose monitors
  • Urine glucose strips
  • Blood gas electrolyte analysis
  • Reagents, clips, and cartridges
  • Blood gas & electrolyte analyzers
• Immunodiagnostics
  • Lateral flow assays
  • Rapid tests
  • Strip readers (Lateral flow readers)
  • Elisa tests
  • Allergen-specific immunodiagnostic tests
  • Immunoassay analyzers
  • Other immunodiagnostic Animal Types
• Hematology
  • Cartridges
  • Analyzers
• Urinalysis
  • Clips & cartridges/panels
  • Urine Analyzers
  • Urine test strips
• Molecular diagnostics
  • Polymerase chain reaction tests
  • Microarrays
  • Other molecular diagnostic Animal Types
• Other Companion Animal Diagnostic Technologies

Global Companion Animal Diagnostics Market Size by Animal Type & CAGR (2026-2033)

• Market Overview
• Dogs
• Cats
• Horses
• Other companion animals

Global Companion Animal Diagnostics Market Size by Application & CAGR (2026-2033)

• Market Overview
• Clinical Pathology
• Bacteriology
• Virology
• Parasitology
• Other Applications

Global Companion Animal Diagnostics Market Size by End User & CAGR (2026-2033)

• Market Overview
• Diagnostic Laboratories
• Veterinary Hospitals & Clinics
• Research Institutes & Universities
• Home-care Settings

Global Companion Animal Diagnostics Market Size & CAGR (2026-2033)

• North America (Technology, Animal Type, Application, End User)
  • US
  • Canada
• Europe (Technology, Animal Type, Application, End User)
  • UK
  • Germany
  • Spain
  • France
  • Italy
  • Rest of Europe
• Asia-Pacific (Technology, Animal Type, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America (Technology, Animal Type, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Technology, Animal Type, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Idexx Laboratories, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zoetis Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biomerieux SA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Virbac
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Neogen Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fujifilm Holdings Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Indical Bioscience GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Idvet
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Randox Laboratories, Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bionote, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Skyla Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Urit Medical Electronic Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nova Biomedical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fassisi GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Swissavans AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Alvedia
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Megacor Veterinary Diagnostics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biopanda Reagents Ltd
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Anipoc Ltd
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ring Biotechnology Co Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendation